The UK High Court has referred questions to the CJEU regarding interpretation of Article 3(b) of the SPC Regulation (EC 469/2009).
HGF's second IP in Retail Conference Amsterdam will take place on 3rd December.
The EPO’s Technical Board of Appeal 3.3.09 in T0694/16 has clarified that claims to purposively selected patients for treatment with a known drug is novel over the prior art treatment of a broader and/or overlapping patient group with the same drug.
HGF Partner Dr Richard Williams will be attending and speaking at IP Protection for Plant Innovation event in Amsterdam on 28-29 November.
HGF are sponsoring IQPC Life Science IP conference on 26-27 November in London with Partner Martyn Fish and Legal Director Michelle Davies attending and speaking.
HGF Partner Dr Claire Irvine will be hosting a roundtable on Navigating the CRISPR patent and licensing landscape at Life Sciences Patent Network Europe 2019 on 21st November.